PTC Therapeutics (NASDAQ:PTCT) Sets New 52-Week High After Analyst Upgrade
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Friday after JPMorgan Chase & Co. raised their price target on the stock from $72.00 to $78.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. PTC Therapeutics traded as high as $55.65 […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Friday after JPMorgan Chase & Co. raised their price target on the stock from $72.00 to $78.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. PTC Therapeutics traded as high as $55.65 […]
